Home
Pontifax Management 4 G.P. reported a 11.8% stake in Keros Therapeutics KROS · 4,787,331 sh · amendment
Trade details
- Type
- 5% stake report
- Report
- 13D · amendment
- Stake
- 11.8%
- Last report
- No earlier report
- Shares held
- 4,787,331 sh
- Class
- Common Stock, Par Value $0.0001 Per Share
- Event date
- 25/04/17
- Filed
- 25/04/18
11.8% stake
Keros Therapeutics trades, last 26 weeks
What else happened in Keros Therapeutics around then
Filed or reported within 30 days of the trade day · 25/03/18~25/05/17Pontifax Management 4 G.P.'s other 5% stake reports
- Pontifax Management 4 G.P.
5% stakeAgomAb Therapeutics
5% stakeAgomAb Therapeutics
AGMB
6.8% stake
3,305,846 sh
6.8% stake
Filed 04/16
- Pontifax Management 4 G.P.
5% stakeKeros Therapeutics
5% stakeKeros Therapeutics
KROS
0% stake
0 sh
0% stake
Filed 25/10/16
- Pontifax Management 4 G.P.
5% stakeLB Pharmaceuticals
5% stakeLB Pharmaceuticals
LBRX
6.3% stake
1,411,681 sh
6.3% stake
Filed 25/09/25
- Pontifax Management 4 G.P.
5% stakeClimb Bio
5% stakeClimb Bio
CLYM
7.7% stake
5,206,380 sh
7.7% stake
Filed 25/09/18
